BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia

Azacitidine (AZA), the reference treatment for most higher-risk myelodysplastic (MDS) patients can also improve overall survival (OS) in elderly acute myeloid leukemia (AML) patients ineligible for intensive chemotherapy, but reliable biological markers predicting response and OS in patients treated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Vidal, Valérie, Robert, Guillaume, Goursaud, Laure, Durand, Laetitia, Ginet, Clemence, Karsenti, Jean Michel, Luciano, Frederic, Gastaud, Lauris, Garnier, Georges, Braun, Thorsten, Hirsch, Pierre, Raffoux, Emmanuel, Nloga, Anne Marie, Padua, Rose Ann, Dombret, Hervé, Rohrlich, Pierre, Ades, Lionel, Chomienne, Christine, Auberger, Patrick, Fenaux, Pierre, Cluzeau, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564547/
https://ncbi.nlm.nih.gov/pubmed/28514758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17482
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados